Vaccine Development

Hepatitis C Vaccine Represents Major Mutations in Isolates

Published in Hepatitis Weekly, July 24th, 2000

University of California at Davis medical researchers have developed a vaccine for the hepatitis C virus (HCV) that includes a significant number of mutations commonly found in a specific portion of the virus.

M.P. Carlos and colleagues reported their work at Immunology 2000, the Joint Annual Meeting of the American Association of Immunologists and the Clinical Immunological Society, held in Seattle, Washington. Describing the nature of the hepatitis C virus, Carlos et al. said, "Upon entry into its host, HCV undergoes a high rate of mutation resulting in marked sequence variation between isolates. These mutants account for the HCV persistence seen in infected...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry